Literature DB >> 8383674

Structural requirements for the binding of modified proteins to the scavenger receptor of macrophages.

H Zhang1, Y Yang, U P Steinbrecher.   

Abstract

Oxidized low density lipoprotein (LDL) and certain chemically modified LDL are recognized by the scavenger receptor of macrophages. All of these modifications involve charge-neutralizing derivatization of lysine amino groups. However, it remains controversial whether recognition of modified LDL by this receptor is due to the modification per se, or to other factors such as a conformational change of apoB. In this study, LDL and other proteins including bovine serum albumin, human high density lipoprotein, and murine IgG were derivatized with oxidation products generated from arachidonic acid by thermal autoxidation. Modified proteins had increased negative charge, and showed a more than 10-fold enhancement of degradation by mouse peritoneal macrophages via the scavenger receptor pathway. Modification was prevented by blocking lysine residues of the proteins by prior reductive methylation. Amino acid analysis revealed dose-dependent modification of lysine residues with no significant effects on any other amino acid. Fab fragments of monoclonal antibodies specific for adducts of oxidation products with lysine prevented the uptake of oxidation product-modified LDL and oxidized LDL by macrophages. Chromatography of oxidation product-modified LDL over Sepharose CL-4B showed that uptake by macrophages did not require LDL aggregation. These results suggest that a relatively simple domain consisting of a cluster of suitably derivatized lysine residues is sufficient for recognition by the scavenger receptor of macrophages.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383674

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

Authors:  W Palinski; S Hörkkö; E Miller; U P Steinbrecher; H C Powell; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Implication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophages.

Authors:  Konstantinos P Markakis; Maria K Koropouli; Stavroula Grammenou-Savvoglou; Ewoud C van Winden; Andromaxi A Dimitriou; Constantinos A Demopoulos; Alexandros D Tselepis; Eleni E Kotsifaki
Journal:  J Lipid Res       Date:  2010-03-23       Impact factor: 5.922

Review 3.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

4.  SR-A regulates the inflammatory activation of astrocytes.

Authors:  P Murgas; F A Cornejo; G Merino; R von Bernhardi
Journal:  Neurotox Res       Date:  2013-10-11       Impact factor: 3.911

5.  Scavenger receptor class A ligands induce secretion of IL1β and exert a modulatory effect on the inflammatory activation of astrocytes in culture.

Authors:  B Godoy; P Murgas; J Tichauer; R Von Bernhardi
Journal:  J Neuroimmunol       Date:  2012-06-26       Impact factor: 3.478

6.  Absence of an effect of vitamin E on protein and lipid radical formation during lipoperoxidation of LDL by lipoxygenase.

Authors:  Douglas Ganini; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

7.  Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia.

Authors:  S Wölle; D P Via; L Chan; J A Cornicelli; C L Bisgaier
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma.

Authors:  David F Schaeffer; Maziar Riazy; Kuljit S Parhar; Johnny H Chen; Vincent Duronio; Tatsuya Sawamura; Urs P Steinbrecher
Journal:  J Lipid Res       Date:  2009-04-09       Impact factor: 5.922

9.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.

Authors:  S Hörkkö; D A Bird; E Miller; H Itabe; N Leitinger; G Subbanagounder; J A Berliner; P Friedman; E A Dennis; L K Curtiss; W Palinski; J L Witztum
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.

Authors:  Nicole M Plourde; Sandhya Kortagere; William Welsh; Prabhas V Moghe
Journal:  Biomacromolecules       Date:  2009-06-08       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.